SKI Market

A+| A| A-|

Indian Indices

Sensex

76,704.13 633.29
( 0.83%)

Global Indices

Nasdaq

47,030.54 63.12
(0.13%)

Dow Jones

6,739.22 18.84
(0.28%)

Hang Seng

55,100.12 1,399.73
(2.61%)

Nikkei 225

10,406.71 89.02
(0.86%)

Forex

USD-INR

92.33 0.01
(0.01%)

EUR-INR

105.92 0.52
(0.49%)

GBP-INR

122.63 0.58
(0.47%)

JPY-INR

0.58 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

22.59

103513.05

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.25

Back

emerald finserv ltd

IVP standalone net profit rises 85.19% in the September 2025 quarter

Nov 05,2025

Net profit of IVP rose 85.19% to Rs 4.00 crore in the quarter ended September 2025 as against Rs 2.16 crore during the previous quarter ended September 2024. Sales rose 20.44% to Rs 146.95 crore in the quarter ended September 2025 as against Rs 122.01 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	146.95	122.01	20
OPM %	5.51	4.53	-
PBDT	6.80	4.50	51
PBT	5.30	3.09	72
NP	4.00	2.16	85

76,704.13 633.29 ( 0.83%)

47,030.54 63.12 (0.13%)

6,739.22 18.84 (0.28%)

55,100.12 1,399.73 (2.61%)

10,406.71 89.02 (0.86%)

92.33 0.01 (0.01%)

105.92 0.52 (0.49%)

122.63 0.58 (0.47%)

0.58 0.00 (0.31%)